February 2019 Briefing - Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Adjuvant Tx for Early Testicular Cancer Does Not Harm Sperm

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- For clinical stage I testicular cancer (TC) patients, adjuvant treatment after orchiectomy has no long-term significant effect on sperm production, according to a study published online Feb. 25 in the Annals of Oncology.

Abstract/Full Text

Stewardship Programs Decrease Inpatient Fluoroquinolone Rx

WEDNESDAY, Feb. 27, 2019 (HealthDay News) -- Fluoroquinolone stewardship interventions at hospitals are associated with less fluoroquinolone prescribing during hospitalization but not at discharge, according to a study published online Feb. 13 in Clinical Infectious Diseases.

Abstract/Full Text

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) -- From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

National Health Spending Set to Increase 5.5 Percent Annually

FRIDAY, Feb. 22, 2019 (HealthDay News) -- National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.

Abstract/Full Text (subscription or payment may be required)

FDA: Gout Drug Uloric Increases Risk of Death

FRIDAY, Feb. 22, 2019 (HealthDay News) -- The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration.

More Information

Most Patients Do Not Disclose Complementary Medicine Use

FRIDAY, Feb. 22, 2019 (HealthDay News) -- Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.

Abstract/Full Text

Intervention Can Reduce Orders for Inpatient Urine Cultures

FRIDAY, Feb. 22, 2019 (HealthDay News) -- An intervention that makes changes to urine testing orderables can reduce the urine culturing rate, according to a study published online Feb. 21 in Infection Control & Hospital Epidemiology.

Abstract/Full Text

Many Experience Improvement in Sex Life After Bariatric Surgery

THURSDAY, Feb. 21, 2019 (HealthDay News) -- About half of women and men who report some level of dissatisfaction with their sexual life prior to bariatric surgery experience clinically meaningful improvement during five years of follow-up, according to a study published online Feb. 20 in JAMA Surgery.

Abstract/Full Text
Editorial (subscription or payment may be required)

Vertical Integration Has Little Impact on Quality Measures

THURSDAY, Feb. 21, 2019 (HealthDay News) -- Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.

Abstract/Full Text

Experimental Test May Quickly Diagnose Sepsis

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A blood test that can quickly diagnose dangerous sepsis infections has been developed, according to research published in the Feb. 1 issue of Biosensors and Bioelectronics.

CNN Article
Abstract/Full Text

New Kaiser Permanente Medical School Plans to Waive Tuition

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- A new medical school to be opened by California-based health system Kaiser Permanente will waive tuition for all students in its first five graduating classes.

The New York Times Article
More Information

Plazomicin Noninferior to Meropenem for Complicated UTI

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- Plazomicin is noninferior to meropenem for patients with complicated urinary tract infections (UTIs), according to a study and a research letter published in the Feb. 21 issue of the New England Journal of Medicine.

Abstract/Full Text - Wagenlehner (subscription or payment may be required)
Abstract/Full Text - McKinnell (subscription or payment may be required)
Editorial (subscription or payment may be required)

Black-White Cancer Mortality Gap Decreasing in Some Age Groups

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- Cancer death rates are decreasing faster in blacks than whites in the United States, according to a report published online Feb. 14 in CA: A Cancer Journal for Clinicians.

Abstract/Full Text

Hospital Prices Growing Faster Than Physician Prices

FRIDAY, Feb. 15, 2019 (HealthDay News) -- Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014, according to a report published in the February issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Health Care Spending Per Person Increased to $5,641 in 2017

TUESDAY, Feb. 12, 2019 (HealthDay News) -- In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.

Health Care Cost and Utilization Report

Many Systematic Reviews Do Not Fully Report Adverse Events

TUESDAY, Feb. 12, 2019 (HealthDay News) -- Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology.

Abstract/Full Text

Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer

TUESDAY, Feb. 12, 2019 (HealthDay News) -- From 2010 to 2015, there was an increase in use of active surveillance or watchful waiting (AS/WW) rates in men with low-risk and intermediate-risk localized prostate cancer, according to a research letter published online Feb. 11 in the Journal of the American Medical Association.

Abstract/Full Text

Predictors of Kidney Stone Recurrence Identified

FRIDAY, Feb. 8, 2019 (HealthDay News) -- A model has been developed for predicting recurrence among kidney stone formers, according to a study published in the February issue of the Mayo Clinic Proceedings.

Abstract/Full Text

Johnson & Johnson to Provide Drug Prices in TV Ads

FRIDAY, Feb. 8, 2019 (HealthDay News) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads.

AP News Article

Value-Based Incentive Program Does Not Cut Catheter-Linked UTIs

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- Federal value-based incentive programs (VBIPs) are not associated with reductions in device-associated catheter-associated urinary tract infection (CAUTI) rates, according to a research letter published in the Feb. 5 issue of the Journal of the American Medical Association.

Abstract/Full Text (subscription or payment may be required)

California Bill Would Tighten Controls on Children's Genitalia Surgery

TUESDAY, Feb. 5, 2019 (HealthDay News) -- A bill that would place more restrictions on children's genitalia surgery in California raises serious concerns among doctors in the state. Under the bill, doctors would not be able to treat or perform surgery on children born with genitals that do not match a single gender or are otherwise atypical unless such surgery is medically necessary or the child consents, the Associated Press reported.

AP News Article

Last Updated: